Successful use of tocilizumab in a case of multicentric Castleman's disease and end-stage renal disease

Ther Apher Dial. 2014 Apr;18(2):210-1. doi: 10.1111/1744-9987.12128. Epub 2013 Oct 31.

Authors

Kei Nagai¹, Atsushi Ueda, Kunihiro Yamagata

Affiliation

¹ Departments of Nephrology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan; Kidney and Dialysis Center, Namegata Distinct General Hospital, Namegata, Ibaraki, Japan. [email protected].

PMID: 24571441
DOI: 10.1111/1744-9987.12128

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged
Antibodies, Monoclonal, Humanized / therapeutic use*
Castleman Disease / blood
Castleman Disease / therapy*
Humans
Interleukin-6 / blood
Kidney Failure, Chronic / blood
Kidney Failure, Chronic / therapy*
Male

Substances

Antibodies, Monoclonal, Humanized
IL6 protein, human
Interleukin-6
tocilizumab

Supplementary concepts

Multi-centric Castleman's Disease